| NYC Business Group
Two Promising Vaccines Are Being Highly Considered.
Oxford-AstraZeneca vaccine candidate triggered the production of both antibodies and T cells, which can recognize and attack virus cells.
In the early trial results for the two vaccine candidates showed that both were safe and could induce immune responses in participants. But the next phase will be critical to demonstrate that the potential vaccines can protect against infections, the articles linked states, Find Out More Here.